# Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease

> **NCT04819217** · NA · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 180 (estimated)

## Conditions studied

- CKD

## Interventions

- **DIETARY_SUPPLEMENT:** Active bamboo charcoal
- **DIETARY_SUPPLEMENT:** Probiotics

## Key facts

- **NCT ID:** NCT04819217
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-01
- **Primary completion:** 2030-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04819217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04819217, "Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04819217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*